OSCR

PD-1 Blockade-Induced DKK1 Expression by CD8+ T Cells Promotes Blood-Brain Barrier Permeabilization.

Overview

13 affiliations
  1. Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel
  2. Rappaport Technion Integrated Cancer Center, Technion - Israel Institute of Technology, Haifa, Israel
  3. Department of Neurology, Rambam Healthcare Campus, Haifa, Israel
  4. Biomedical Core Facility, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
  5. Department of Neuroscience, Monash University, Melbourne, Australia
  6. Department of Psychiatry, Rambam Healthcare Campus, Haifa, Israel
  7. Department of Radiology Rambam Healthcare Campus, Haifa, Israel
  8. Oncohost LTD., Binyamina, Israel
  9. Department of Oncology, Rambam Healthcare Campus, Haifa, Israel
  10. Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik, University of Heidelberg, Heidelberg, Germany
  11. Translational Lung Research Center (TLRC) at German Center for Lung Research (DZL), Heidelberg, Germany
  12. Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany
  13. Department of Medical Oncology, Thorax Clinic, Heidelberg, Germany
Journal: Cancer discovery, volume 16, issue 5, pages 976-992
Dates: received 12 July 2025; accepted 9 January 2026; published online 13 January 2026; in print 1 May 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1158/2159-8290.cd-25-1222 · PMID 41525686 · PMCID PMC13133603 · OpenAlex W7123336909
Open access: hybrid, a free copy (OpenAlex)
Status: code found, still to be checked (how the code is found and verified)
Categories: human (organism), mouse (organism), other condition (population), cellular / molecular (subfield)
Methods: Statistics
MeSH: Blood-Brain Barrier*, Brain Neoplasms*, CD8-Positive T-Lymphocytes*, Immune Checkpoint Inhibitors*, Intercellular Signaling Peptides and Proteins*, Programmed Cell Death 1 Receptor*, Animals, Female, Humans, Mice (* major topic)
Journal subjects: Immunology, Tumor Resistance to Immune Response, Immunotherapy, Checkpoint Blockade, Tumor Microenvironment, Immune Cells and the Microenvironment
Topic: Brain Metastases and Treatment (Oncology, Medicine), according to OpenAlex
Funding: Israel Cancer Research Fund (23-103)
Citations: cited by 1 paper (Europe PMC); 49 references in the paper
Research resources: 4T1 RRID:CVCL_0125, Murine EMT6 RRID:CVCL_1923, RRID:CVCL_2252, LLC RRID:CVCL_4358, R version 4.1.0 software RRID:SCR_001905, RRID:SCR_002798

Abstract

Anti–PD-1 therapy benefits a subset of patients with brain metastasis (BrM); however, heterogeneous responses imply an incomplete understanding of the brain−immune ecosystem. To elucidate host-driven determinants of this variability, we performed single-cell RNA sequencing to characterize the brain microenvironment. Although anti–PD-1 induced robust antitumor immune activation, it uniquely, among all immune checkpoint inhibitors (ICI) tested, compromised blood–brain barrier (BBB) integrity. This permeabilization was mediated by DKK1-expressing activated CD8+ T cells through the induction of β-catenin/TCF and FOXM1 pathways, contributing to endothelial cell destabilization. Depleting plasma DKK1 restored BBB integrity and reduced experimental BrM formation. Clinically, patients with lung cancer receiving anti–PD-1 exhibited increased magnetic resonance imaging contrast enhancement in the brain, suggestive of BBB perturbations, and increasing plasma DKK1 levels correlated with higher BrM incidence in nonresponders. Sequential administration of anti–PD-1 followed by cisplatin improved intracranial cisplatin delivery and therapeutic efficacy in ICI-resistant BrM. These findings identify anti-PD-1–induced BBB modulation as a tractable vulnerability in BrM management.

Significance: Our study demonstrates that PD-1 blockade induces DKK1 expression in activated CD8+ T cells, leading to BBB permeabilization. This previously unrecognized host-driven mechanism may explain heterogeneous intracranial responses to immunotherapy and identifies BBB modulation as a therapeutic opportunity to enhance drug delivery and efficacy for BrM.

See related commentary by Karreman and Winkler, p. 831

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

No file of the authors' code could be read here: it is described below, and read at its source.

codeocean:4833035

License: none: the authors keep all their rights
State: cannot be verified, verified on 28 September 2026
Evidence: found in the paper
Software Heritage: not checked
Found in: “Data Availability”
Not found: README, license file, CITATION.cff, environment file, tests, continuous integration, documentation
Availability: 1 check, the latest on 28 September 2026: cannot be verified
  • 28 September 2026: cannot be verified

The paper's code and data availability statement is in the Data section.

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 0 scripts, each with its path and the digest of its content;
  • no match between paragraphs and code yet;
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

No dataset and no data link were found in the paper.

Data Availability

The scRNA-seq dataset generated in the current study is publicly available in the Code Ocean repository at https://codeocean.com/capsule/4833035/tree/v1.

(https://codeocean.com/widget.js?slug=4833035)

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Publisher: n/a → American Association for Cancer Research

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 20 authors, 10 MeSH terms, 1 funder, 49 references, 6 RRIDs.

Cite

This paper

Deo, A., Levin, S., Buxbaum, C., Benguigui, M., Manobla, B., Saar, G., Bosak, N., Bergmann, E., Eran, A., Grinfeld, A., Harel, M., Lahav, C., Raviv, Z., Daher, S., Zer, A., Reuter, J. H., Heuβel, C. P., Christopoulos, P., Yizhak, K., & Shaked, Y. (2026). PD-1 Blockade-Induced DKK1 Expression by CD8+ T Cells Promotes Blood-Brain Barrier Permeabilization. Cancer discovery, 16(5), 976-992. https://doi.org/10.1158/2159-8290.cd-25-1222

BibTeX

@article{deo2026pd,
author = {Deo, Abhilash and Levin, Sapir and Buxbaum, Chen and Benguigui, Madeleine and Manobla, Bar and Saar, Galit and Bosak, Noam and Bergmann, Eyal and Eran, Ayelet and Grinfeld, Anat and Harel, Michal and Lahav, Coren and Raviv, Ziv and Daher, Sameh and Zer, Alona and Reuter, Julia Helena and Heuβel, Claus Peter and Christopoulos, Petros and Yizhak, Keren and Shaked, Yuval},
title = {{PD-1 Blockade-Induced DKK1 Expression by CD8+ T Cells Promotes Blood-Brain Barrier Permeabilization}},
journal = {Cancer discovery},
year = {2026},
month = may,
volume = {16},
number = {5},
pages = {976--992},
publisher = {American Association for Cancer Research},
issn = {2159-8274},
doi = {10.1158/2159-8290.cd-25-1222},
url = {https://doi.org/10.1158/2159-8290.cd-25-1222},
pmid = {41525686},
pmcid = {PMC13133603}
}

RIS

TY - JOUR
AU - Deo, Abhilash
AU - Levin, Sapir
AU - Buxbaum, Chen
AU - Benguigui, Madeleine
AU - Manobla, Bar
AU - Saar, Galit
AU - Bosak, Noam
AU - Bergmann, Eyal
AU - Eran, Ayelet
AU - Grinfeld, Anat
AU - Harel, Michal
AU - Lahav, Coren
AU - Raviv, Ziv
AU - Daher, Sameh
AU - Zer, Alona
AU - Reuter, Julia Helena
AU - Heuβel, Claus Peter
AU - Christopoulos, Petros
AU - Yizhak, Keren
AU - Shaked, Yuval
TI - PD-1 Blockade-Induced DKK1 Expression by CD8+ T Cells Promotes Blood-Brain Barrier Permeabilization
T2 - Cancer discovery
J2 - Cancer Discov
PY - 2026
DA - 2026/05/01
VL - 16
IS - 5
SP - 976
EP - 992
SN - 2159-8274
PB - American Association for Cancer Research
DO - 10.1158/2159-8290.cd-25-1222
UR - https://doi.org/10.1158/2159-8290.cd-25-1222
LA - en
ER -

CSL-JSON

{
"id": "10.1158/2159-8290.cd-25-1222",
"type": "article-journal",
"title": "PD-1 Blockade-Induced DKK1 Expression by CD8+ T Cells Promotes Blood-Brain Barrier Permeabilization",
"container-title": "Cancer discovery",
"author": [
{
"family": "Deo",
"given": "Abhilash"
},
{
"family": "Levin",
"given": "Sapir"
},
{
"family": "Buxbaum",
"given": "Chen"
},
{
"family": "Benguigui",
"given": "Madeleine"
},
{
"family": "Manobla",
"given": "Bar"
},
{
"family": "Saar",
"given": "Galit"
},
{
"family": "Bosak",
"given": "Noam"
},
{
"family": "Bergmann",
"given": "Eyal"
},
{
"family": "Eran",
"given": "Ayelet"
},
{
"family": "Grinfeld",
"given": "Anat"
},
{
"family": "Harel",
"given": "Michal"
},
{
"family": "Lahav",
"given": "Coren"
},
{
"family": "Raviv",
"given": "Ziv"
},
{
"family": "Daher",
"given": "Sameh"
},
{
"family": "Zer",
"given": "Alona"
},
{
"family": "Reuter",
"given": "Julia Helena"
},
{
"family": "Heuβel",
"given": "Claus Peter"
},
{
"family": "Christopoulos",
"given": "Petros"
},
{
"family": "Yizhak",
"given": "Keren"
},
{
"family": "Shaked",
"given": "Yuval"
}
],
"container-title-short": "Cancer Discov",
"volume": "16",
"issue": "5",
"page": "976-992",
"DOI": "10.1158/2159-8290.cd-25-1222",
"PMID": "41525686",
"PMCID": "PMC13133603",
"ISSN": "2159-8274",
"publisher": "American Association for Cancer Research",
"URL": "https://doi.org/10.1158/2159-8290.cd-25-1222",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
1
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1093/brain/awae347
CCL2 blockade combined with PD-1/P-selectin immunomodulators impedes breast cancer brain metastasis.
Journal: Brain : a journal of neurology
In common: other condition, mouse, cellular / molecular, 4 references
[2] doi:10.1093/oncolo/oyac064
Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases.
Journal: The oncologist
In common: other condition, 4 references
[3] doi:10.1016/j.celrep.2021.110268 [code]
Disrupted neural correlates of anesthesia and sleep reveal early circuit dysfunctions in Alzheimer models.
Journal: Cell reports
In common: mouse, author Michal Harel
[4] doi:10.1002/advs.76803
ICOS-ImmunoPET Monitors T Cell Activation After Combination Immune Checkpoint Blockade in a Mouse Model of Melanoma Brain Metastasis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
In common: other condition, mouse, cellular / molecular, 3 references
[5] doi:10.1016/j.dib.2023.109795
Datasets assessing lipid-content in optically cleared brains.
Journal: Data in brief
In common: author Galit Saar
[6] doi:10.1158/2159-8290.cd-24-0134
TIMP1 Mediates Astrocyte-Dependent Local Immunosuppression in Brain Metastasis Acting on Infiltrating CD8+ T Cells.
Journal: Cancer discovery
In common: other condition, mouse, cellular / molecular, 3 references
[7] doi:10.1172/jci.insight.187716
Endothelial PROX1 induces blood-brain barrier disruption in the central nervous system.
Journal: JCI insight
In common: other condition, mouse, cellular / molecular, 3 references
[8] doi:10.1172/jci.insight.199498
Distinct immune landscapes characterize highly versus minimally invasive brain metastases.
Journal: JCI insight
In common: other condition, mouse, 3 references
[9] doi:10.1186/s40478-025-02007-x
Identification and characterization of tertiary lymphoid structures in brain metastases.
Journal: Acta neuropathologica communications
In common: other condition, cellular / molecular, 3 references
[10] doi:10.1136/jitc-2024-009522
Natural killer cells are required for the recruitment of CD8+ T cells and the efficacy of immune checkpoint blockade in melanoma brain metastases.
Journal: Journal for immunotherapy of cancer
In common: other condition, mouse, 3 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Add the badge to the code's README

OSCR: the badge of this paper

If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.

Markdown
<!-- oscr-badge:start -->
[![OSCR](https://openscicode.org/badge/doi/10.1158/2159-8290.cd-25-1222.svg)](https://openscicode.org/badge/doi/10.1158/2159-8290.cd-25-1222)
<!-- oscr-badge:end -->
reStructuredText
.. oscr-badge:start

.. image:: https://openscicode.org/badge/doi/10.1158/2159-8290.cd-25-1222.svg
   :target: https://openscicode.org/badge/doi/10.1158/2159-8290.cd-25-1222
   :alt: OSCR

.. oscr-badge:end
HTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1158/2159-8290.cd-25-1222"><img src="https://openscicode.org/badge/doi/10.1158/2159-8290.cd-25-1222.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->

If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Report a mismatch between the code and the paper · Report a code error (signed in)

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Report a reproduction failure (signed in)

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.